Amrize Ltd $AMRZ Shares Sold by Sumitomo Mitsui Trust Group Inc.

Sumitomo Mitsui Trust Group Inc. decreased its position in shares of Amrize Ltd (NYSE:AMRZ) by 4.2% during the third quarter, HoldingsChannel reports. The fund owned 357,735 shares of the company’s stock after selling 15,856 shares during the quarter. Sumitomo Mitsui Trust Group Inc.’s holdings in Amrize were worth $13,376,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. Continuum Advisory LLC purchased a new stake in shares of Amrize in the second quarter valued at $62,000. Mirae Asset Global Investments Co. Ltd. purchased a new position in shares of Amrize during the 3rd quarter worth about $49,000. IFP Advisors Inc boosted its stake in shares of Amrize by 1,707.3% during the 3rd quarter. IFP Advisors Inc now owns 1,988 shares of the company’s stock worth $74,000 after purchasing an additional 1,878 shares during the period. NewEdge Advisors LLC boosted its stake in shares of Amrize by 1,419.7% during the 2nd quarter. NewEdge Advisors LLC now owns 2,082 shares of the company’s stock worth $111,000 after purchasing an additional 1,945 shares during the period. Finally, Oslo Pensjonsforsikring AS bought a new position in Amrize during the 1st quarter valued at about $133,000.

Insider Activity

In other news, insider Mario Gross purchased 3,568 shares of the stock in a transaction that occurred on Tuesday, August 11th. The stock was purchased at an average price of $46.60 per share, for a total transaction of $166,268.80. Following the completion of the acquisition, the insider owned 38,485 shares of the company’s stock, valued at approximately $1,793,401. This trade represents a 10.22% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, CFO Baris Oran acquired 3,000 shares of the company’s stock in a transaction that occurred on Tuesday, August 11th. The stock was purchased at an average cost of $47.38 per share, for a total transaction of $142,140.00. Following the purchase, the chief financial officer owned 3,000 shares of the company’s stock, valued at $142,140. This represents a ? increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. In the last ninety days, insiders have purchased 48,983 shares of company stock valued at $2,158,755. Insiders own 0.54% of the company’s stock.

Amrize Trading Down 3.4%

Shares of AMRZ opened at $42.63 on Friday. Amrize Ltd has a 1-year low of $35.78 and a 1-year high of $65.94. The company has a 50-day moving average of $39.57 and a 200 day moving average of $50.35. The firm has a market capitalization of $23.58 billion, a price-to-earnings ratio of 19.29, a PEG ratio of 1.73 and a beta of 0.04. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.07 and a quick ratio of 0.67.

Amrize (NYSE:AMRZ) last issued its earnings results on Wednesday, October 28th. The company reported $1.05 EPS for the quarter, hitting analysts’ consensus estimates of $1.05. The business had revenue of $3.77 billion for the quarter. Amrize had a net margin of 9.93% and a return on equity of 10.02%. Amrize’s revenue was up 2.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.98 earnings per share. On average, research analysts expect that Amrize Ltd will post 2.30 EPS for the current year.

Amrize Dividend Announcement

The business also recently declared a dividend, which will be paid on Wednesday, November 18th. Stockholders of record on Tuesday, November 10th will be paid a dividend of $0.11 per share. The ex-dividend date of this dividend is Tuesday, November 10th. Amrize’s payout ratio is currently 4.98%.

Analysts Set New Price Targets

A number of research firms recently weighed in on AMRZ. Weiss Ratings lowered shares of Amrize from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Thursday, October 8th. JPMorgan Chase & Co. dropped their target price on Amrize from $52.00 to $48.00 and set a “neutral” rating for the company in a research report on Tuesday, October 13th. Barclays dropped their target price on Amrize from $55.00 to $40.00 and set an “equal weight” rating for the company in a research report on Monday, October 19th. Deutsche Bank Aktiengesellschaft cut their target price on Amrize from $64.00 to $56.00 and set a “buy” rating on the stock in a research note on Wednesday, September 23rd. Finally, Oppenheimer reduced their price target on Amrize from $55.00 to $52.00 and set an “outperform” rating on the stock in a report on Monday. Eight analysts have rated the stock with a Buy rating, six have assigned a Hold rating and four have given a Sell rating to the company. According to data from MarketBeat.com, Amrize currently has a consensus rating of “Hold” and an average target price of $49.06.

Amrize Company Profile

Amrize is a North American building-solutions company that supplies materials and products used in residential, commercial and infrastructure construction. Its portfolio includes cement, aggregates, ready-mix concrete, asphalt, roofing systems and other building products.

The company serves customers across the United States and Canada through a network of production facilities, distribution locations and related operations. Its products support applications ranging from roads, bridges and other public infrastructure to commercial buildings and residential construction.

Amrize was formed through the separation of Holcim’s North American business and began trading independently on the New York Stock Exchange under the symbol AMRZ in 2025.